Immunodominant minor histocompatibility antigen peptides recognized by cytolytic T lymphocytes primed by indirect presentation

Transplantation

Volumn 65, Issue 4, 1998, Pages 559-569

  Nevala, Wendy K ^a   Paul, Claire ^a   Wettstein, Peter J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; CROSSES, GENETIC; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GRAFT REJECTION; HETEROZYGOTE; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTE TRANSFUSION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; MINOR HISTOCOMPATIBILITY ANTIGENS; RECOMBINATION, GENETIC; SKIN TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032570542     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199802270-00018     Document Type: Article

References (28)

1. Matzinger P, Bevan MJ. Induction of H-2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted. Cell Immunol 1977; 33: 92.
2. Wettstein PJ, Haughton G, Frelinger JA. H-2 effects on cell-cell interaction in the immune response to single non-H-2 alloantigens. I. H-2D region control of immunogenicity and lack of restriction in vivo. J Exp Med 1977; 146: 1346.
3. Huang AYC, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994; 264: 961.
4. Mazzarella RA, Green M. ERp99, an abundant, conserved glycoprotein of the endoplasmic reticulum, is homolgous to the 90-kDa heat shock protein (hsp90) and the 94-kDa glucose regulated protein (GRP94). J Biol Chem 1987; 262: 8875.
5. Li Z, Srivastava PK. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. EMBO J 1993; 12: 3143.
6. Suto R, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995; 269: 1585.
7. Arnold D, Faath S, Rammensee HG, Schild H. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med 1995; 182: 885.
8. Huang AYC, Bruce AT, Pardoll DM, Levitsky HI. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 1996; 4: 349.
9. Wettstein PJ, Bailey DW. Immunodominance in the immune response to "multiple" histocompatibility antigens. Immunogenetics 1982; 16: 47.
10. Nevala WK, Wettstein PJ. The preferential CTL response to immunodominant minor histocompatibility antigen peptides. Transplantation 1996; 62: 283.
11. b molecules. Transplantation 1997; 64(9): 1323.
12. Nevala WK, Paul C, Wettstein PJ. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo. J Immunol 1997; 158: 1102.
13. Geller RL, Loudovaris T, Neuenfeldt S, Johnson RC, Brauker JH. Use of an immunoisolation device for cell transplantation and tumor immunotherapy. N Y Acad Sci (in press).
14. Bailey DW. Recombinant inbred strains. Transplantation 1971; 11: 325.
15. Ljunggren HG, Karre K. Host resistance directed selectively against H-2-deficient lymphoma variants: analysis of the mechanism. J Exp Med 1985; 162: 1745.
16. Schumacher TNM, Heemels MT, Neefjes JJ, Kast WM, Melief CJM, Ploegh HL. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 1990; 62: 563.
17. Ljunggren H, Stam NJ, Ohlen C, et al. Empty MHC class I molecules come out in the cold. Nature 1990; 346: 476.
18. Bailey DW, Usama B. A rapid method of grafting skin on tails of mice. Transplant Bull 1960; 7: 424.
19. Geller RL, Neuenfeldt S, Levon SA, Maryanov DA, Thomas TJ, Brauker JH. Immunoisolation of tumor cells: generation of anti-tumor immunity through indirect presentation of antigen. J Immunother 1997; 20: 131.
20. Wettstein PJ, van Bleek GM, Nathenson SG. Differential binding of a minor histocompatibility antigen peptide to H-2 class I molecules correlates with immune responsiveness. J Immunol 1993; 150: 2753.
21. Von Boehmer H, Hengartner H, Nabholz M, Lernhardt W, Schreier MH, Haas W. Fine specificity of a continuously growing killer cell clone specific for H-Y antigen. Eur J Immunol 1979; 9: 592.
22. Hammerling GJ, Hammerling U, Lemke H. Isolation of twelve monoclonal antibodies against Ia and H-2 antigens: serological characterization and reactivity with B and T lymphocytes. Immunogenetics 1979; 8: 433.
23. Jones B, Janeway CA, Jr. Cooperative interaction of B lymphocytes with antigen- specific helper T lymphocytes is MHC restricted. Nature 1981; 292: 547.
24. Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci USA 1993; 90: 4942.
25. Wettstein P. Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. II. Observation of a hierarchy among dominant antigens. Immunogenetics 1986; 24: 24.
26. Wolpert E, Franksson L, Karre K. Dominant and cryptic antigens in the MHC class I restricted T cell response across a complex minor histocompatibility barrier: analysis and mapping by elution of cellular peptides. Int Immunol 1995; 7: 919.
27. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271.
28. Norbury CC, Hewlett LJ, Prescott AR, Shastri N, Watts C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 1995; 3: 783.